Biophotonics and Biotechnology in Pancreatic Cancer: Cyclic RGD-Peptide-Conjugated Type II Quantum Dots for in vivo Imaging

Publisher： Karger

E-ISSN： 1424-3911|10|5|553-564

ISSN： 1424-3903

Source： Pancreatology, Vol.10, Iss.5, 2010-10, pp. : 553-564

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vivo toxicity of quantum dots: no cause for concern?

By Yong Ken-Tye   Swihart Mark T  

Nanomedicine, Vol. 7, Iss. 11, 2012-11 ,pp. : 1641-1643

Future Medicine

Access to resources Recommend Favorite

RGD Peptide–mediated Molecular Imaging for Targeting Integrin Alpha(v) Beta(3) in Tumors: A Review

By  

Current Medical Imaging Reviews, Vol. 14, Iss. 2, 2018-02 ,pp. : 186-195

Bentham Science Publishers

Access to resources Recommend Favorite

Fighting cancer: the potential of quantum dots and rods

By  

Nanomedicine, Vol. 2, Iss. 2, 2007-04 ,pp. : 149-152

Future Medicine

Access to resources Recommend Favorite

In vivo Radioiodide Imaging and Treatment of Pancreatic Cancer Xenografts after MUC1 Promoter-Driven Expression of the Human Sodium-Iodide Symporter

By  

Pancreatology, Vol. 7, Iss. 5-6, 2007-10 ,pp. : 505-513

Karger

Access to resources Recommend Favorite

Quantum dots for tumor-targeted drug delivery and cell imaging

By Misra R DK  

Nanomedicine, Vol. 3, Iss. 3, 2008-06 ,pp. : 271-274

Future Medicine

Access to resources Recommend Favorite